B O O K - American College of Rheumatology

Lilian H. D. van Tuyl 8 , Karin Britsemmer 3 , David T. Felson 2 , George
A. Wells 6 , Josef S. Smolen 4 , Bin Zhang 1 , Julia Funovits 5 , Dirkjan
van Schaardenburg 3 and Maarten Boers 7 , 1 Boston Univ Schl of
Medicine, Boston, MA, 2 Boston University School of Medicine,
Boston, MA, 3 Jan van Breemen Institute, 4 Krankenhaus Lainz,
Vienna, Austria, 5 Medical University of Vienna, 6 Univ of Ottawa
Faculty of Med, Ottawa, ON, Canada, 7 VU University Medical
Center, Amsterdam, The Netherlands, 8 VU University Medical
Center, Amsterdam
A311
Systemic Sclerosis, Fibrosing Syndromes, and
Raynaud’s - Clinical Aspects and Therapeutics I
Moderators: Laura K. Hummers, MD; Johns Hopkins University;
Baltimore, MD
Maureen D. Mayes, MD, MPH; University of Texas-Houston;
Houston, TX
4:30 PM
724. Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential
Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis.
Minoru Hasegawa, Manabu Fujimoto and Kazuhiko Takehara,
Kanazawa University
4:45 PM
725. HLA DRB1*0407 and *1304 Are Predictive Biomarkers for
Scleroderma Renal Crisis.
Binh Y. Nguyen 1 , Maureen D. Mayes 6 , Frank C. Arnett 7 , Deborah
J. del Junco 2 , Emilio B. Gonzalez 4 , Hilda T. Draeger 3 , Marilyn
Perry 2 , Amir Hendiani 2 , John D. Reveille 5 and Shervin Assassi 1 ,
1
Univ of Texas Health Science Center Houston, Houston, TX,
2
Univ of Texas Health Science Center Houston, 3 Univ of Texas
Health Science Center San Antonio, San Antonio, TX, 4 Univ of
Texas Medical Branch, Galveston, TX, 5 Univ Texas Health Sci Ctr,
Houston, TX, 6 University of Texas-Houston, Houston, TX, 7 UT
Medical School, Houston, TX
5:00 PM
726. GAVE (Gastric Antral Vascular Ectasia) in Early
Diffuse SSc: Updated Report from the SCOT (Scleroderma
Cyclophosphamide or Transplant) Trial.
Emily W. Hung 9 , Maureen D. Mayes 10 , Lynette Keyes-Elstein 5 ,
Leslie J. Crofford 6 , Mary Ellen Csuka 3 , Daniel E. Furst 8 , Ellen
Goldmuntz 4 , Peter McSweeney 11 , Richard Nash 2 , Victor
Machicao 7 and Keith Sullivan 1 , 1 Duke University Medical Center,
for the SCOT Trial Investigators, Durham, NC, 2 Fred Hutchinson
Cancer Research Center, 3 Medical College of Wisconsin,
Milwaukee, WI, 4 NIAID, 5 Rho Federal Systems Inc., 6 Univ of
KY, Lexington, KY, 7 Univ of Texas Health Science Center at
Houston, 8 University of California Los Angeles Medical School,
Los Angeles, CA, 9 University of Texas at Houston, Houston, TX,
10
University of Texas-Houston, Houston, TX, 11 US Oncology
5:15 PM
727. A Formula To Predict Mean Pulmonary Artery Pressures
in Patients with Connective Tissue Disease Based on
Echocardiography, NTproBNP and O2 Saturation.
Benjamin E. Schreiber 3 , Christopher J. Valerio 3 , Clive Handler 3 ,
Greg Keir 1 , Athol U. Wells 1 , Christopher P. Denton 2 and J. Gerry
Coghlan 3 , 1 Royal Brompton Hospital, London, 2 Royal Free
Hospital, London, United Kingdom, 3 Royal Free Hospital, London,
London, United Kingdom
5:30 PM
728. Predictive Factors of Hand Radiographic Lesions in
Systemic Sclerosis: A Prospective Study.
Jerome Avouac 4 , Giulia Mogavero 1 , Henri Guérini 2 , Jean-Luc
Drapé 2 , Alessandro Mathieu 1 , Andre Kahan 3 and Yannick
Allanore 3 , 1 2nd Chair of Rheumatology, University of Cagliari,
Cagliari, Italy, 2 Paris Descartes University, Radiology B
Department, Cochin Hospital, APHP, Paris, France, 3 Paris
Descartes University, Rheumatology A Department, Cochin
Hospital, APHP, Paris, France, 4 Paris Descartes University,
Rheumatology A Department, Cochin Hospital, APHP, Paris,
France
5:45 PM
729. Predictive Value of Non-Invasive Tests for the Diagnosis
of Scleroderma-Associated Pulmonary Hypertension: PHAROS
Registry.
Dinesh Khanna 4 , Rajeev Saggar 4 , Daniel E. Furst 4 , Yannick
Allanore 3 , James R. Seibold 5 , Philip J. Clements 4 , Rajan Saggar 4 ,
Chi-hong Tseng 4 , Paul Maranian 4 , Monique Hinchcliff 2 , Virginia
Steen 1 and PHAROS Investigators, 1 Georgetown University,
2
Northwestern Univ, 3 Paris Descartes University, 4 UCLA, 5 Univ of
Connecticut
ACR Meet the Professor Sessions
4:30 - 6:00 PM
Admission to each Meet the Professor session requires a
separate registration and ticket. To verify which session you
registered for, check to make sure the registration code on your
ticket matches the code listed below in parentheses.
B207
Antiphospholipid Syndrome (021) f PS
Speaker: Doruk Erkan, MD; Hospital for Special Surgery; New
York, NY
Upon completion of this session, participants should be able to:
• discuss the spectrum of antiphospholipid syndrome
• determine the diagnostic utility of antiphospholipid antibody
tests
• describe the controversial aspects of primary and secondary
thrombosis prevention in antiphospholipid syndrome
• discuss the management of catastrophic antiphospholipid
syndrome patients
B208
Crystal: Management of Gout (022) PS
Speaker: Hyon K. Choi, MD, DrPH; University of British Columbia;
Vancouver, BC, Canada
Upon completion of this session, participants should be able to:
• discuss the management of gout in patients with renal
insufficiency or organ transplants
• identify strategies to treat patients who are intolerant of
approved therapies
• cite agents in development for the treatment of
hyperuricemia and gout
B209
Fibromyalgia (023) PM
Speaker: Manuel Martinez-Lavin, MD; National Cardiology
Institute; Mexico City, Mexico
2010 Program Book 51
monday